John Johnson Xeris Biopharma Holdings, Inc. (XERS) insider trading activity
John Johnson is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 698,083 shares of XERS, which is worth approximately $5.06 Million. The most recent transaction as insider was on Dec 19, 2025, when has been sold 135,400 shares (Common Stock) at a price of $7.22 per share, resulting in proceeds of $977,588. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
698K
16.25%
3M change
21.65%
12M change
Total Value Held
$5.06 Million
JOHN JOHNSON Transaction History
Also insider at
JJ
John Johnson
Director
Trevose, PA